It also disturbs hepatic functions, also in type 1 diabetic patients, especially with poor glycemia control, causing hepatopathies, such as glycogenic hepatopathy, in which altered activities of AST or ALT are hallmarks [79]. This evidence concerns the gene GPT and Decreased liver function.